Professor of Medicine, Cumming School of Medicine, University of Calgary, Alberta, Canada

Vincent Wong holds the position of Mok Hing Yiu Professor of Medicine and serves as the Head (Academic) of the Division of Gastroenterology and Hepatology at The Chinese University of Hong Kong. His research primarily revolves around steatotic liver disease and liver fibrosis, with a particular focus on the development and application of non-invasive tests for screening, diagnosis and prognostication.

I am an Associate Professor of Medicine in the Karsh Division of Gastroenterology and Hepatology and the Medical Director of the Liver Cancer Program at Cedars-Sinai Cancer. My research program has been focused on clinical and translational research of liver cancer. I have extensive experience in epidemiology of liver cirrhosis risk stratification, surveillance, cancer early detection, diagnosis, and treatment.

Dr. Amar Bansal is a nephrologist and palliative care physician at the University of Pittsburgh. He is the Associate Program Director for the nephrology training program. He has an interest in AKI-HRS and serious illness communication. He is the course director for "GiTalk," a communication workshop based on VitalTalk designed for GI providers. It is held annually for GI fellows and APP's at UPMC.

Dr. Gedallovich is a current Transplant Hepatology Fellow at Stanford University. Prior to this, she completed Gastroenterology fellowship at Stanford University and Hospice & Palliative Medicine fellowship at the University of California San Francisco.

Transplant Hepatologist at Northwell Health with a focus on Palliative Care and Care Coordination. I completed my Hospice & Palliative Medicine, Gastroenterology, and Transplant Hepatology training at Mount Sinai Hospital.

Dr. Rachel Adams is the Physician Executive Director of the MedStar Palliative Care Service Line, which includes nine inpatient palliative care programs across hospitals in Washington, D.C. and Maryland. The service line also features PATCH, an outpatient telemedicine program, and a novel advance care planning initiative that helps ensure patients' wishes are thoughtfully gathered and documented in the medical record.<br><br>Dr. Adams also serves as an Assistant Professor of Medicine at MedStar Georgetown University Hospital (MGUH), where she works clinically.

Dr. Schnabl is a trained gastroenterologist and physician-scientist. He is Professor of Medicine in the Department of Medicine at the University of California San Diego, founding Director of the NIH-supported San Diego Digestive Diseases Research Center (SDDRC) and Director of Research for the Division of Gastroenterology. His research focus is to understand the complex multi-directional interactions that occur between the gut microbiota and the liver.

Dr David J. Pinato is a Clinician Scientist and Consultant Medical Oncologist working within the Department of Surgery and Cancer at Imperial College in London. <br><br>He is Director of Developmental Cancer Therapeutics at Imperial College, where he leads a translational research program focusing on the early clinical implementation of novel experimental anticancer therapies to the clinic, with particular emphasis on anti-cancer immunotherapy.

Prof. Dr. Mathias Heikenwälder is a trained molecular biologist, with expertise in immunology and a strong link to translational research evoked by 10 years of work and expertise in a Pathology Institution (Clinical Pathology, University Hospital Zurich). Since October 2015 he is Department head at the German Cancer Research Center (DKFZ) in Heidelberg focusing on the link between chronic inflammation and cancer. Since October 2022 he is director of the M3 Research Center, University Tübingen. Prof.